This inventor holds 2 USPTO granted patents. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2010-2011.
Company Filing History:
Years Active: 2010-2011
Title: Ted H. Elsasser: Innovator in Adrenomedullin Research
Introduction
Ted H. Elsasser is a notable inventor based in Berwyn Heights, MD (US). He has made significant contributions to the field of biomedical research, particularly in the study of adrenomedullin (AM) and its associated binding proteins. With a total of 2 patents, his work has implications for diagnosing and treating various AM-related diseases.
Latest Patents
Elsasser's latest patents focus on the determination of AM-binding proteins and their association with adrenomedullin. The inventions provide methods for the isolation, identification, and purification of AM-binding proteins. These methods are crucial for diagnosing, treating, and monitoring diseases associated with abnormally elevated AM levels. Furthermore, his patents detail the identification of a complex between AM and a specific AM-binding protein, factor H (fH). The inventions also include methods for utilizing these complexes and antibodies to treat conditions such as cancer and diabetes.
Career Highlights
Ted H. Elsasser is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution has allowed him to contribute to groundbreaking research in the field of health and medicine.
Collaborations
Elsasser has collaborated with notable colleagues, including Frank Cuttitta and Alfredo Martinez. These partnerships have further enhanced the impact of his research and innovations.
Conclusion
Ted H. Elsasser's contributions to the field of adrenomedullin research exemplify the importance of innovation in medical science. His patents and collaborations continue to pave the way for advancements in diagnosing and treating critical health conditions.